BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1507584)

  • 41. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria.
    Fabiani ME; Story DF
    Pharmacol Res; 1995 Sep; 32(3):155-63. PubMed ID: 8745346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of guinea-pig tracheal smooth muscle responsiveness by the potassium channel openers NIP-121 and cromakalim.
    Shikada K; Yamamoto A; Tanaka S
    Jpn J Pharmacol; 1992; 58 Suppl 2():334P. PubMed ID: 1507583
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of the effects of putative activators of K+ channels on pancreatic B-cell function.
    Plant TD; Garrino MG; Henquin JC
    Pflugers Arch; 1989; 414 Suppl 1():S152-3. PubMed ID: 2528721
    [No Abstract]   [Full Text] [Related]  

  • 45. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
    Grover GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two different types of channels are targets for potassium channel openers in Xenopus oocytes.
    Honoré E; Lazdunski M
    FEBS Lett; 1991 Aug; 287(1-2):75-9. PubMed ID: 1908792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of contractile responses of human myometrium and intramyometrial arteries by potassium channel openers.
    Kostrzewska A; Laudański T; Batra S
    Acta Obstet Gynecol Scand; 1996 Nov; 75(10):886-91. PubMed ID: 9003087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein.
    Hu SL; Kim HS; Okolie P; Weiss GB
    J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD; Clapham JC; Wilson C; Hamilton TC
    J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro.
    Malmgren A; Andersson KE; Andersson PO; Fovaeus M; Sjögren C
    J Urol; 1990 Apr; 143(4):828-34. PubMed ID: 2313820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium.
    Lau WM
    Pharmacology; 1992; 45(1):9-16. PubMed ID: 1508969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of K+ channels in the relaxant responses to various agonists in estrogen primed rat uterus.
    Mehta AA; Dave KC; Goyal RK
    Indian J Physiol Pharmacol; 1995 Apr; 39(2):140-4. PubMed ID: 7649602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators.
    Fish FA; Prakash C; Roden DM
    Circulation; 1990 Oct; 82(4):1362-9. PubMed ID: 1698129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice.
    Del Pozo E; Barrios M; Baeyens JM
    Pharmacol Toxicol; 1990 Aug; 67(2):182-4. PubMed ID: 2255672
    [No Abstract]   [Full Text] [Related]  

  • 55. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.
    McCulloch AI; Randall MD
    Br J Pharmacol; 1996 Mar; 117(5):859-66. PubMed ID: 8851502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
    Wilson C
    J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.
    Randall MD; Ujiie H; Griffith TM
    Br J Pharmacol; 1994 May; 112(1):49-54. PubMed ID: 8032661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative electrophysiological and mechanical actions of ATP-sensitive potassium channel openers in canine Purkinje fibers.
    Satoh H
    Gen Pharmacol; 1993 May; 24(3):565-75. PubMed ID: 8365637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of pinacidil and cromakalim on vascular relaxation and sympathetic neurotransmission.
    Cai B; Hao Q; Greenberg SS; deBoisblanc B; Gillott D; Goharderakhshan R; Summer WR; Hyman A; Lippton H
    Can J Physiol Pharmacol; 1994 Jul; 72(7):801-10. PubMed ID: 7828089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
    Baczkó I; Leprán I; Papp JG
    Eur J Pharmacol; 1997 Apr; 324(1):77-83. PubMed ID: 9137916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.